AposHealth
New York
About AposHealth
We at AposHealth® are passionate about revolutionizing the treatment of musculoskeletal conditions by simply addressing peoples’ gait to help alleviate pain and help them move better and live better. Our flagship solution, Apos®, is FDA-cleared to temporarily reduce knee pain caused by osteoarthritis. It can also be used as a general wellness device to help patients live well with chronic lower back and hip pain. With a 96 percent satisfaction rate, over 150,000 patients treated, and dozens of peer-reviewed publications supporting the science behind Apos® as well as its clinical effect, this system’consisting of gait analysis, personalized foot-worn device, and a customized treatment plan’has helped patients with chronic knee, lower back, and hip pain worldwide move, live, and thrive.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: Less than $1M
- Total funding: $44.5M
- Funding stage: Early Stage Venture
- Last round: Series A (Feb 2020)
- Website: aposhealth.com
- Phone: 888-599-9109
Industries & Categories
Health Care, Hospital, Medical, Medical Device, Personal Health
Social Profiles
Canonical: https://fsome.com/organization/aposhealth-37967 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.